Skip Navigation LinksHome > September 2013 - Volume 32 - Issue 9 > Raltegravir In Vitro Effect on Bilirubin Binding
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e31829044a8
HIV Reports

Raltegravir In Vitro Effect on Bilirubin Binding

Clarke, Diana F. PharmD*; Wong, Ronald J. PhD; Wenning, Larissa PhD; Stevenson, David K. MD; Mirochnick, Mark MD*

Collapse Box


Drugs that displace bilirubin from albumin may increase the risk of kernicterus in neonates. We evaluated the effect of raltegravir on bilirubin–albumin binding in pooled neonatal serum using the peroxidase method. Raltegravir had minimal effect on bilirubin–albumin binding at concentrations of 5 and 10 µM, caused a small but statistically significant increase in unbound bilirubin at 100 µM and caused potentially harmful increases at 500 and 1000 µM. Our data suggest that the effect of raltegravir on neonatal bilirubin binding is unlikely to be clinically significant at typical peak concentrations reached with usual dosing.

© 2013 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.